Yao‐Chun Hsu

8.8k total citations · 3 hit papers
120 papers, 3.7k citations indexed

About

Yao‐Chun Hsu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yao‐Chun Hsu has authored 120 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 72 papers in Hepatology and 38 papers in Surgery. Recurrent topics in Yao‐Chun Hsu's work include Liver Disease Diagnosis and Treatment (66 papers), Hepatitis C virus research (54 papers) and Hepatitis B Virus Studies (52 papers). Yao‐Chun Hsu is often cited by papers focused on Liver Disease Diagnosis and Treatment (66 papers), Hepatitis C virus research (54 papers) and Hepatitis B Virus Studies (52 papers). Yao‐Chun Hsu collaborates with scholars based in Taiwan, United States and Japan. Yao‐Chun Hsu's co-authors include Chun‐Ying Wu, Ming‐Shiang Wu, Jaw‐Town Lin, Hsiu J. Ho, Yi–Ju Chen, Mindie H. Nguyen, Ken N. Kuo, Daniel Q. Huang, Yen‐Tsung Huang and Teng‐Yu Lee and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Yao‐Chun Hsu

112 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

2012 710 citations Chun‐Ying Wu, Yi–Ju Chen et al. profile →
Global burden of hepatitis B virus: current status, missed opportunities and a call for action

2023 267 citations Yao‐Chun Hsu, Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology profile →
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions

2024 55 citations Lung‐Yi Mak, Ken Liu et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Yao‐Chun Hsu

EPIDE

HEPAT

SURGE

GASTR

Christos Triantos Greece

Mirella Fraquelli Italy

Hyung Joon Yim South Korea

Christine Silvain France

Jean P. Molleston United States

Gian Paolo Caviglia Italy

Hiroki Nishikawa Japan

Frédéric Oberti France

Davide Giuseppe Ribaldone Italy

Guy Neff United States

Christos Triantos Greece

Yao‐Chun Hsu

2.1k ×1.0

EPIDE

2.4k ×1.3

HEPAT

1.1k ×1.2

SURGE

243 ×0.6

GASTR

385 ×1.3

Citations per year, relative to Yao‐Chun Hsu Yao‐Chun Hsu (= 1×) peers Christos Triantos

Countries citing papers authored by Yao‐Chun Hsu

Since Specialization

Citations

This map shows the geographic impact of Yao‐Chun Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao‐Chun Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao‐Chun Hsu more than expected).

Fields of papers citing papers by Yao‐Chun Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao‐Chun Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao‐Chun Hsu. The network helps show where Yao‐Chun Hsu may publish in the future.

Co-authorship network of co-authors of Yao‐Chun Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yao‐Chun Hsu. A scholar is included among the top collaborators of Yao‐Chun Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao‐Chun Hsu. Yao‐Chun Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.

Tseng, Cheng‐Hao, Teng‐Yu Lee, Chi‐Yi Chen, et al.. (2025). Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 40(5). 1245–1254.

Mak, Lung‐Yi, Jimmy Che‐To Lai, Ken Liu, et al.. (2025). Chronic Hepatitis B Infection: Patient Guidance. Journal of Gastroenterology and Hepatology. 41(1). 61–77.

Wu, Jia‐Ling, et al.. (2025). Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal. Alimentary Pharmacology & Therapeutics. 61(7). 1208–1217.

Mak, Lung‐Yi, Ken Liu, Sakkarin Chirapongsathorn, et al.. (2024). Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nature Reviews Gastroenterology & Hepatology. 21(12). 834–851. 55 indexed citations breakdown →

Hsu, Yao‐Chun, Chi-Yi Chen, Cheng‐Hao Tseng, et al.. (2024). Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial. Clinical and Molecular Hepatology. 31(1). 213–226.

Hsu, Yao‐Chun, et al.. (2024). Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study. Journal of Epidemiology. 35(1). 21–29.

Hsu, Yao‐Chun, et al.. (2024). Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and bibliometric analysis. International Journal of Surgery. 110(11). 7234–7244. 3 indexed citations

Hsu, Yao‐Chun, Teng‐Yu Lee, Mindie H. Nguyen, et al.. (2023). Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population‐based cohort study. Alimentary Pharmacology & Therapeutics. 58(4). 463–473. 10 indexed citations

10.

Huang, Chi‐Cheng, Chih‐Yi Liu, Yao‐Chun Hsu, et al.. (2022). Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing. International Journal of Molecular Sciences. 23(3). 1579–1579. 1 indexed citations

11.

Yi, Chih‐Hsun, Ming‐Jong Bair, Jen‐Hung Wang, et al.. (2022). Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection. Journal of Microbiology Immunology and Infection. 55(4). 643–650. 2 indexed citations

12.

Yeh, Ming‐Lun, Pei‐Chien Tsai, Shu‐Chi Wang, et al.. (2021). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. Cancers. 13(14). 3455–3455. 12 indexed citations

13.

Tseng, Cheng‐Hao, Yao‐Chun Hsu, Fanpu Ji, et al.. (2020). Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. The Lancet. Gastroenterology & hepatology. 5(12). 1039–1052. 73 indexed citations

14.

Kao, Feng‐Chen, Yao‐Chun Hsu, Chang–Bi Wang, Yuan‐Kun Tu, & Pao‐Hsin Liu. (2018). Short-term and long-term revision rates after lumbar spine discectomy versus laminectomy: a population-based cohort study. BMJ Open. 8(7). e021028–e021028. 8 indexed citations

15.

Wei, Yu-Feng, et al.. (2018). Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study. BMJ Open. 8(1). e019661–e019661. 18 indexed citations

16.

Wu, Chun‐Ying, Yao‐Chun Hsu, Hsiu J. Ho, et al.. (2015). Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut. 65(4). 693–701. 57 indexed citations

17.

Hsu, Yao‐Chun, Hsiu J. Ho, Yen‐Tsung Huang, et al.. (2014). Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut. 64(3). 495–503. 163 indexed citations

18.

Hsu, Yao‐Chun, Hsiu J. Ho, Ming‐Shiang Wu, Jaw‐Town Lin, & Chun‐Ying Wu. (2013). Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology. 58(1). 150–157. 62 indexed citations

19.

Hsu, Yao‐Chun, Jyh‐Ming Liou, Shih‐Cheng Liao, et al.. (2009). Psychopathology and Personality Trait in Subgroups of Functional Dyspepsia Based on Rome III Criteria. The American Journal of Gastroenterology. 104(10). 2534–2542. 41 indexed citations

20.

Hsu, Yao‐Chun, Chin‐Lin Perng, Chaur‐Shine Wang, et al.. (2009). A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. British Journal of Clinical Pharmacology. 69(3). 245–251. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact